Colorectal Cancer Epidemiology and Screening in 2025

UCSF School of Medicine

S. Gupta

Year in Review 2024 - Transformative FDA Approvals in Precision Onco…

Oncology 2024 Year in Review

V. Subbiah

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

Year in Review 2024 - Colorectal Cancer

Oncology 2024 Year in Review

R. Kim, T. Biachi

48 Hours in the Life of Receiving a Diagnostic Colonoscopy

UCI Health

A. Dua

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

Cancer Screening in Primary Care: An Evidence-Based Review of Outpat…

UNC Lineberger Comprehensive Cancer Center

N. Robertson

ESMO 2024 Summary: Neoadjuvant Colon Cancer Treatment - Recent Clini…

2024 ESMO Annual Meeting Insights Hub

J. Taieb

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

Surveillance Imaging in Solid Tumors: More Complicated Than It Appea…

ecancer

C. Booth

Rising Trends of Colorectal Cancer Among Millennials

Dr. Iris Gorfinkel

I. Gorfinkel

The Importance of 1L Biomarkers in CRC

Nicholas DeVito

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

Early-Onset CRC: A New Epidemic With Knowns and Unknowns

Ibrahim Sahin

1L Botensilimab + Balstilimab in Stage IV MSS CRC Without Liver Mets…

Nicholas DeVito

Anal Cancer: Risk Factors and Prevention

GRACE

P. Romesser

Personalized MRD Assessment and Treatment Decision-Making in CRC: Up…

UChicago Medicine

B. Polite

Risk Stratification and Screening for Early Onset Colorectal Cancer

Fight Colorectal Cancer

J. Demb, F. May, A. Zauber, I. Lansdorp-Vogelaar, A. Shaukat, J. Perea Garcia, H. Hampel

ASCO® GI 2025 Insights: Encorafenib + Cetuximab +/- Binimetinib in B…

Insights from 2025 ASCO® GI Annual Meeting

Y. Sunakawa

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde